Literature DB >> 28271275

Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management.

Irai S Oliveira1,2, Aoife Kilcoyne3, Jamie M Everett4, Mari Mino-Kenudson4, Mukesh G Harisinghani3, Karthik Ganesan5.   

Abstract

Cholangiocarcinoma is a relatively uncommon malignant neoplasm with poor prognosis. The distinction between extrahepatic and intrahepatic subtypes is important as epidemiological features, biologic and pathologic characteristics, and clinical course are different for both entities. This review study focuses on the role imaging plays in the diagnosis, classification, staging, and post-treatment assessment of cholangiocarcinoma.

Entities:  

Keywords:  Cholangiocarcinoma; Computed tomography; Magnetic resonance imaging; Tumor staging

Mesh:

Substances:

Year:  2017        PMID: 28271275     DOI: 10.1007/s00261-017-1094-7

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  36 in total

Review 1.  Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis.

Authors:  Gábor Lendvai; Tímea Szekerczés; Idikó Illyés; Réka Dóra; Endre Kontsek; Alíz Gógl; András Kiss; Klára Werling; Ilona Kovalszky; Zsuzsa Schaff; Katalin Borka
Journal:  Pathol Oncol Res       Date:  2018-11-17       Impact factor: 3.201

2.  Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at 18F-FDG-PET/CT: prognostic implication of metabolic parameters and tumor markers.

Authors:  A Sabaté-Llobera; L Gràcia-Sánchez; G Reynés-Llompart; E Ramos; L Lladó; J Robles; T Serrano; J Mestres-Martí; C Gámez-Cenzano
Journal:  Clin Transl Oncol       Date:  2018-07-18       Impact factor: 3.405

3.  Multiple biochemical indices and metabolomics of Clonorchis sinensis provide a novel interpretation of biomarkers.

Authors:  Yang-Yuan Qiu; Qiao-Cheng Chang; Jun-Feng Gao; Ming-Jia Bao; Hai-Tao Luo; Jin-Ho Song; Sung-Jong Hong; Rui-Feng Mao; Yun-Yi Sun; Ying-Yu Chen; Ming-Yuan Liu; Chun-Ren Wang; Xiao-Lei Liu
Journal:  Parasit Vectors       Date:  2022-05-19       Impact factor: 4.047

Review 4.  Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives.

Authors:  Alessandro Rizzo; Angela Dalia Ricci; Simona Tavolari; Giovanni Brandi
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

Review 5.  Application of new ultrasound techniques for focal liver lesions.

Authors:  Feiqian Wang; Kazushi Numata; Hiromi Nihonmatsu; Masahiro Okada; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2020-01-16       Impact factor: 1.314

6.  Combination of intraoperative radiofrequency ablation and surgical resection for treatment of cholangiocarcinoma: feasibility and long-term survival.

Authors:  Sang Min Lee; Heung Kyu Ko; Ji Hoon Shin; Jin-Hyoung Kim; Hee Ho Chu
Journal:  Diagn Interv Radiol       Date:  2020-01       Impact factor: 2.630

Review 7.  Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings.

Authors:  Mohammed Saleh; Mayur Virarkar; Vlad Bura; Raul Valenzuela; Sanaz Javadi; Janio Szklaruk; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2020-11

Review 8.  Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic.

Authors:  Massimiliano Cadamuro; Alberto Lasagni; Angela Lamarca; Laura Fouassier; Maria Guido; Samantha Sarcognato; Enrico Gringeri; Umberto Cillo; Mario Strazzabosco; Jose Jg Marin; Jesus M Banales; Luca Fabris
Journal:  Expert Opin Investig Drugs       Date:  2021-02-23       Impact factor: 6.206

9.  A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.

Authors:  Holger Moch; Alwin Krämer; Chantal Pauli; Tilmann Bochtler; Linda Mileshkin; Giulia Baciarello; Ferran Losa; Jeffrey S Ross; George Pentheroudakis; George Zarkavelis; Suayib Yalcin; Mustafa Özgüroğlu; Andreas Beringer; Jeremy Scarato; Mathis Mueller-Ohldach; Marlene Thomas
Journal:  Oncologist       Date:  2021-03-25

10.  Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma.

Authors:  Gauthier Delaby; Bahar Ataeinia; Jennifer Wo; Onofrio Antonio Catalano; Pedram Heidari
Journal:  Abdom Radiol (NY)       Date:  2021-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.